Privium Fund Management B.V. Novartis Ag Transaction History

Privium Fund Management B.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$95.27 - $108.47 $379,174 - $431,710	-3,980 Reduced 39.88%	6,000 $580,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $92,270 - $101,540	-1,000 Reduced 9.11%	9,980 $1.01 Million
Q3 2023 Nov 06, 2023	SELL	$94.73 - $105.13 $215,037 - $238,645	-2,270 Reduced 17.13%	10,980 $1.12 Million
Q1 2023 May 03, 2023	BUY	$80.03 - $92.81 $160,060 - $185,620	2,000 Added 17.78%	13,250 $1.22 Million
Q3 2022 Nov 03, 2022	BUY	$74.61 - $87.26 $839,362 - $981,675	11,250 New	11,250 $861,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

Stay updated on Privium Fund Management B.V. with notifications on news.